Watermark

BGB-3111-214

Completed

Study of Zanubrutinib (BGB-3111) in Participants With Marginal Zone Lymphoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-214

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2018

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20180823

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan Plain Language Summary

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan Plain Language Summary